PRAH

Transfer...
Symbol:
NASDAQ / Sector: Healthcare / Sub-Sector: Diagnostics & Research / Stock Type: Speculative Growth
# of Employee: 12,000 / Fiscal Year End: 2016-12-31 / Stock Type: Small Growth
USD / Exchange Rate: 1 at 2016-11-22 /

PRA Health Sciences Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries.

Competitors

Competitors List | Key Matrix Details

TMO | Q | A | LH | DGX | IDXX | QGEN | PKI | DXCM | BIO | BIO.B | ICLR | BRKR | VWR | ALR | CRL | PRXL |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeROEFCFMarginFCFPerSharEquityPerSProfitMargContinuousNetMarginDebtEquityCurrentRat
2012-12-25Annual46.10%11.60%2.04.434.10%-0.40%-0.40%.218.944
2013-12-25Annual-6.20%-2.10%-0.711.627.50%-4.50%-4.50%.2421.025
2014-12-25Annual-0.70%-0.30%-0.115.827.90%-2.40%-2.40%.433.954
2015-12-25Annual17.20%7.50%1.911.130.30%5.10%5.10%.460.924

Key Ratio Trend

ReportDatePeriodTypeROEFCFMarginFCFPerSharEquityPerSProfitMargContinuousNetMarginDebtEquityCurrentRat
AverageAnnual21.32%17.78%11.72%14.12%-5.48%-310.56%-310.56%9.42%-4.41%
2013-12-25Annual-113.45%-118.10%-134.96%161.46%-19.35%-1,025.00%-1,025.00%11.01%8.58%
2014-12-25Annual88.71%85.71%85.06%35.95%1.45%46.67%46.67%78.93%-6.93%
2015-12-25Annual2,557.14%2,600.00%1,886.92%-29.53%8.60%312.50%312.50%6.24%-3.14%


Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2012-12-25Annual699,736k461,236k0.0-2,707k-2,707k39,641,k34.10%-0.40%-0.40%
2013-12-25Annual1,390,161k1,007,274k86,136k-62,234k-62,234k40,268,k27.50%-4.50%-4.50%
2014-12-25Annual1,459,586k1,052,208k0.0-35,742k-35,742k42,897,k27.90%-2.40%-2.40%
2015-12-25Annual1,613,883k1,124,564k0.081,765k81,765k63,207,k30.30%5.10%5.10%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
AverageAnnual8.71%6.07%0.00%-704.62%-704.62%4.88%-5.48%-310.56%-310.56%
2013-12-25Annual98.67%118.39%0.00%-2,199.00%-2,199.00%1.58%-19.35%-1,025.00%-1,025.00%
2014-12-25Annual4.99%4.46%-100.00%42.57%42.57%6.53%1.45%46.67%46.67%
2015-12-25Annual10.57%6.88%0.00%328.76%328.76%47.35%8.60%312.50%312.50%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2012-12-25Annual175,957k806,568k324,235k305,918k500,650k.218.944
2013-12-25Annual467,335k1,927,399k457,994k469,264k1,458,135k.2421.025
2014-12-25Annual676,815k1,561,762k488,723k466,356k1,095,406k.433.954
2015-12-25Annual702,722k1,526,021k573,776k529,980k996,041k.460.924

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
AverageAnnual31.16%-7.85%13.84%8.89%-14.34%9.42%-4.41%
2013-12-25Annual165.60%138.96%41.25%53.40%191.25%11.01%8.58%
2014-12-25Annual44.82%-18.97%6.71%-0.62%-24.88%78.93%-6.93%
2015-12-25Annual3.83%-2.29%17.40%13.64%-9.07%6.24%-3.14%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeOperatingCCAPEXFreeCashFlInvestmentFinancialF
2012-12-25Annual99,259k-18,067k81,192k-18,058k-42,157k
2013-12-25Annual-23,939k-4,910k-28,849k-1,018,959k1,115,041k
2014-12-25Annual22,747k-27,323k-4,576k-12,259k8,294k
2015-12-25Annual153,676k-32,814k120,862k-71,686k-42,444k

Cash Flow Trend

ReportDatePeriodTypeOperatingCCAPEXFreeCashFlInvestmentFinancialF
AverageAnnual88.64%-165.56%10.91%-2,170.74%-270.09%
2013-12-25Annual-124.12%72.82%-135.53%-5,542.70%2,744.97%
2014-12-25Annual195.02%-456.48%84.14%98.80%-99.26%
2015-12-25Annual575.59%-20.10%2,741.22%-484.76%-611.74%



Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Revenue000000699736k1390161k1459586k1613883k
2: Cost of revenue000000461236k1007274k1052208k1124564k
3: Gross profit000000238500k382887k407378k489319k
4: Operating expenses000000192890k370388k350539k325021k
5: Research and development0000000000
6: Sales, General and administrative000000160643k270703k253970k246417k
7: Restructuring, merger and acquisition0000000000
8: Other operating expenses00000032247k99685k96569k78604k
9: Operating income00000045610k12499k56839k164298k
10: Interest Expense000000086136k00
11: Other income (expense)000000-50164k-9393k-98691k-49133k
12: Income before taxes000000-4554k-83030k-41852k115165k
13: Provision for income taxes000000-1847k-22041k-8154k30004k
14: Other income0000000-1245k-2044k-3396k
15: Net income from continuing operations000000-2707k-62234k-35742k81765k
16: Net income from discontinuing ops0000000000
17: Extraordinary items0000000000
18: Cumulative effect of accounting changes0000000000
19: Other0000000000
20: Net income000000-2707k-62234k-35742k81765k
21: Preferred dividend0000000000
22: Net income available to common shareholders000000-2707k-62234k-35742k81765k
23: Earnings per share0000000000
24: Basic000000-0.07-1.55-0.831.36
25: Diluted000000-0.07-1.55-0.831.29
26: Weighted average shares outstanding0000000000
27: Basic00000039641k40268k42897k59965k
28: Diluted00000039641k40268k42897k63207k
29: EBITDA00000076297k102565k153403k242250k
30: Total operating expenses000000192890k370388k350539k325021k


Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Assets000000982525k2394734k2238577k2228743k
2: Current assets000000324235k457994k488723k573776k
3: Cash000000109211k72155k85192k121065k
4: Cash and cash equivalents000000109211k72155k85192k121065k
5: Short-term investments0000000000
6: Receivables000000125139k232639k235058k288322k
7: Inventories0000000000
8: Deferred income taxes0000008833k29224k20949k0
9: Prepaid expenses00000018208k27222k33396k30175k
10: Other current assets00000062844k96754k114128k134214k
11: Non-current assets000000658290k1936740k1749854k1654967k
12: Property, plant and equipment00000050961k75827k72933k80691k
13: Gross property, plant and equipment000000112696k81985k101474k127667k
14: Accumulated Depreciation000000-61735k-6158k-28541k-46976k
15: Equity and other investments00000003246k1213k1288k
16: Goodwill000000490675k1099081k1033999k1014798k
17: Intangible assets000000108374k699791k600910k533938k
18: Deferred income taxes000000422k1026k933k3069k
19: Prepaid pension benefit0000000000
20: Other long-term assets0000007858k57769k39866k21183k
21: Liabilities and stockholders' equity000000982525k2394734k2238577k2228743k
22: Liabilities000000806568k1927399k1561762k1526021k
23: Current liabilities000000305918k469264k466356k529980k
24: Short-term debt0000003358k18900k00
25: Capital leases0000000000
26: Accounts payable00000017314k27686k39100k57096k
27: Deferred income taxes000000146k416k181k0
28: Taxes payable0000006113k11073k17733k19262k
29: Accrued liabilities00000056378k115300k110779k83800k
30: Deferred revenues000000221162k295889k296121k333729k
31: Other current liabilities0000001447k02442k36093k
32: Non-current liabilities000000500650k1458135k1095406k996041k
33: Long-term debt000000451076k1245812k948537k889514k
34: Capital leases0000000000
35: Deferred taxes liabilities00000026723k185591k106324k81691k
36: Accrued liabilities0000001714k6280k6035k0
37: Deferred revenues0000000000
38: Pensions and other benefits0000000000
39: Minority interest0000000000
40: Other long-term liabilities00000021137k20452k34510k24836k
41: Stockholders' equity000000175957k467335k676815k702722k
42: Preferred stock0000000000
43: Common stock0000004k403k598k602k
44: Other Equity0000000000
45: Additional paid-in capital000000330520k490006k821411k828347k
46: Retained earnings000000-156743k-39943k-75685k6080k
47: Treasury stock0000000000
48: Accumulated other comprehensive income0000002176k16869k-69509k-132307k
49: Total assets000000982525k2394734k2238577k2228743k
50: Total liabilities and stockholders' equity000000982525k2394734k2238577k2228743k
51: Total cash000000109211k72155k85192k121065k
52: Total current assets000000324235k457994k488723k573776k
53: Net property, plant and equipment00000050961k75827k72933k80691k
54: Total non-current assets000000658290k1936740k1749854k1654967k
55: Total current liabilities000000305918k469264k466356k529980k
56: Total non-current liabilities000000500650k1458135k1095406k996041k
57: Total liabilities000000806568k1927399k1561762k1526021k
58: Total stockholders' equity000000175957k467335k676815k702722k


Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Cash Flows From Operating Activities00000099259k-23939k22747k153676k
2: Net income000000-2707k-39943k-35742k81765k
3: Depreciation & amortization00000030687k25333k96564k77952k
4: Amortization of debt discount/premium and issuance costs0000004324k1608k5737k6714k
5: Investment/asset impairment charges0000000000
6: Investments losses (gains)0000000000
7: Deferred income taxes000000-7378k-21980k-31968k-3219k
8: (Gain) Loss from discontinued operations0000000000
9: Extraordinary items0000000000
10: Cumulative effect of accounting change0000000000
11: Stock based compensation00000011610k132k3467k5276k
12: Accounts receivable0000000000
13: Inventory0000000000
14: Prepaid expenses000000-4430k2858k-7980k-10427k
15: Accounts payable0000004982k-46209k19727k36135k
16: Accrued liabilities0000000000
17: Interest payable0000000000
18: Income taxes payable0000000000
19: Other working capital00000046080k45371k-30883k-30423k
20: Other non-cash items00000016091k8891k3825k-10097k
21: Cash Flows From Investing Activities000000-18058k-1018959k-12259k-71686k
22: Investments in property, plant, and equipment000000-18067k-4910k-27323k-32814k
23: Property, plant, and equipment reductions0000009k0044k
24: Acquisitions, net0000000-1014049k0-543k
25: Purchases of investments0000000000
26: Sales/Maturities of investments0000000000
27: Investments in technologies0000000000
28: Sales of technologies0000000000
29: Purchases of intangibles0000000000
30: Sales of intangibles0000000000
31: Other investing activities0000000015064k-38373k
32: Cash Flows From Financing Activities000000-42157k1115041k8294k-42444k
33: Debt issued000000283698k1313443k105m90m
34: Debt repayment000000-224042k-607249k-423775k-130m
35: Preferred stock issued0000000000
36: Preferred stock repaid0000000000
37: Warrant issued0000000000
38: Common stock issued0000000470400k333950k0
39: Common stock repurchased0000000000
40: Excess tax benefit from stock based compensation0000000000
41: Dividend paid000000-101607k-4346k00
42: Dividend payable0000000000
43: Other financing activities000000-206k-57207k-6881k-2444k
44: Effect of exchange rate changes000000787k12k-5745k-3673k
45: Net change in cash00000039831k72155k13037k35873k
46: Cash at beginning of period00000069380k072155k85192k
47: Cash at end of period000000109211k72155k85192k121065k
48: Free Cash Flow0000000000
49: Operating cash flow00000099259k-23939k22747k153676k
50: Capital expenditure000000-18067k-4910k-27323k-32814k
51: Free cash flow00000081192k-28849k-4576k120862k
52: Net cash provided by operating activities00000099259k-23939k22747k153676k
53: Net cash used for investing activities000000-18058k-1018959k-12259k-71686k
54: Net cash provided by (used for) financing activities000000-42157k1115041k8294k-42444k



Note